ABSTRACT NUMBER: ESOC2026LB72 CHARACTERISTICS OF PATIENTS WITH ISCHEMIC STROKE DESPITE ORAL ANTICOAGULATION FOR ATRIAL FIBRILLATION
Abstract Background and aims Breakthough ischemic stroke despite oral anticoagulation (OAC) among patients with atrial fibrillation (AF) remains insufficiently characterized. We aimed to identify characteristics associated with ischemic stroke despite OAC treatment. Methods Prospective data from consecutive patients with ischemic stroke and AF who underwent carotid imaging from 10 stroke registries were included. Patients were categorized in those with i)stroke despite OAC, ii) known AF not on OAC, iii) newly diagnosed AF. Multivariable logistic regression was performed to identify clinical characteristics associated with stroke despite OAC. Results Among 2,551 stroke patients, 30.1% experienced a breakthrough stroke, 32.0% were not receiving OAC despite AF history, and 37.9% had newly diagnosed AF. Patients with breakthrough were older, had a higher cardiovascular comorbidity burden, and presented with milder neurological deficits compared to those not on OACs. Ipsilateral atherosclerotic carotid stenosis was more prevalent in the OAC group (p=0.008). Compared to those not treated with OACs, characteristics associated with breakthrough stroke included increasing age (aOR:1.02/year; 95%CI:1.00–1.03), prior stroke/TIA (aOR:1.67; 1.13–2.47), persistent/permanent AF (aOR:1.49; 1.11–2.01), multiterritorial infarcts (aOR:2.04; 1.27–3.25), hyperlipidemia (aOR:1.4; 1.05–1.90), and cancer (aOR:2.73; 1.10–6.76). Mild ipsilateral carotid stenosis was associated with breakthrough stroke (aOR:1.37; 1.00–1.86), even though stenosis >50% were not associated with breakthrough stroke. Conclusions Breakthrough strokes were associated with older age and higher cardiovascular risk burden. These findings suggest the presence of competing stroke mechanisms beyond cardioembolism and underscore the need for comprehensive vascular risk assessment. Conflict of interest
Authors
- Dimitrios Sagris (ORCID: https://orcid.org/0000-0001-6657-5665)
- Paula Tiili (ORCID: https://orcid.org/0000-0002-7916-7262)
- Anastasia Adamou
- Exuperio Díez‐Tejedor (ORCID: https://orcid.org/0000-0003-2295-1707)
- Davide Strambo (ORCID: https://orcid.org/0000-0003-4429-2714)
- Alexander Tsiskaridze (ORCID: https://orcid.org/0000-0003-4848-4609)
- María Soledad Rodriguez Pérez
- Jorge Rodríguez-Pardo
- Antonio Araúz Góngora
- J Putaala
- Elisa Cuadrado-Godia
- Hooman Kamel
- Blanca Fuentes
- Esmirna Farington-Terrero
- Patrik Michel (ORCID: https://orcid.org/0000-0003-4954-7579)
- A Barboza Miguel
- Eleni Korompoki
- George Ntaios
- Konstantinos Vemmos
- Maia Gomez-Schneider
Institutions
- Tbilisi State University (GE)
- Rafael Advanced Defense Systems (Israel) (IL)
- Universitat Pompeu Fabra (ES)
- Cornell University (US)
- Helsinki University Hospital (FI)
- AHEPA University Hospital (GR)
- Centre Hospitalier Universitaire Vaudois (CH)
- MIND Research Institute (US)
- Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (AR)
- Hospital La Paz Institute for Health Research (ES)
- University Hospital of Larissa (GR)
- Alexandra Hospital (GR)
- Neurological Research Institute (US)
- Instituto Nacional de Neurología y Neurocirugía (MX)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- European Stroke Journal
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1093/esj/aakag023.1920
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00